Table 4.
Comparison of TSQM domains in different DMT groups
| Type of DMT | Effectiveness | Side effects | Convenience | Global satisfaction |
|---|---|---|---|---|
| IFNβ | 75.32±18.90 | 74.53±16.76 | 68.52±21.84 | 69.84±19.20 |
| GA | 72.36±20.61 | 83.08±12.49 | 67.14±20.34 | 67.87±19.86 |
| TFL | 55.55±17.75 | 77.77±20.01 | 80.83±18.81 | 48.36±11.28 |
| DMF | 71.42±17.54 | 81.70±16.68 | 81.73±16.18 | 68.78±20.86 |
| RTX | 64.77±22.92 | 78.42±16.54 | 67.79±23.43 | 62.18±23.51 |
| Fingolimod | 69.18±19.02 | 82.34±15.88 | 89.05±15.22 | 67.10±20.16 |
| Tysabri | 78.88±17.09 | 83.33±16.77 | 78.12±17.10 | 68.94±15.76 |
| OCR | 60.00±21.21 | 70.00±7.07 | 73±21.8 | 55.10±12.30 |
| AZA/Prednisolone | 60.00±.00 | 68.33±25.16 | 77.50±10.60 | 56±8.83 |
| P value | 0.002 | 0.04 | <0.001 | 0.02 |